Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Cocrystal Pharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 2 filings
- 1 insider, $80.4K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$80.4K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Cocrystal Pharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Frost Phillip MD Et Al | Director, 10% Owner | 1,993,551Indirect | Aug 6, 2026 | 11 |
| Sapirstein James | Chief Executive Officer | – | Jun 3, 2026 | 1 |
| Hassan Fred | Director | 1,383,009 | Jan 13, 2026 | 2 |
| Pfenniger Richard C Jr | Director | 31,400 | Jan 13, 2026 | 2 |
| Rubin Steven D | Director | 2,660,242 | Jan 13, 2026 | 1 |
| Kornberg Roger D. | Director | 28,109 | Jan 13, 2026 | 1 |
| Martin James Joseph | Co-CEO and CFO | 44,167 | Jan 13, 2026 | 2 |
| Lee Sam | President and Co-CEO | 76,355 | Jan 13, 2026 | 1 |
| Japour Anthony J | Director | 14,924 | Jan 13, 2026 | 1 |
| Frost Gamma Investments Trust | 10% Owner | 1,319,838Indirect | Apr 6, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 (view filing)5:11 PM ET | Aug 5 | 1 day | Frost Phillip MD Et AlDirector, 10% Owner | PPurchase | +10.0K | $0.9816 | +$9.82K | +0.5%1.99M after | |
| Aug 5, 2026 (view filing)4:10 PM ET | Aug 3 | 2 days | Frost Phillip MD Et AlDirector, 10% Owner | PPurchase | +75.0K | $0.9412 | +$70.6K | +3.9%1.98M after | |
| Feb 25, 2026 (view filing) | Feb 24 | 1 day | Frost Phillip MD Et AlDirector, 10% Owner | PPurchase | +20.0K | $1.00 | +$20.0K | +1.1%1.91M after | |
| Feb 9, 2026 (view filing) | Feb 6 | 3 days | Frost Phillip MD Et AlDirector, 10% Owner | PPurchase | +50.0K | $0.95 | +$47.5K | +2.7%1.89M after | |
| Jan 2, 2026 (view filing) | Dec 31, 2025 | 2 days | Frost Phillip MD Et AlDirector, 10% Owner | PPurchase | +50.0K | $0.95 | +$47.5K | +2.8%1.84M after | |
| Dec 31, 2025 (view filing) | Dec 30 | 1 day | Frost Phillip MD Et AlDirector, 10% Owner | PPurchase | +20.0K | $0.97 | +$19.4K | +1.1%1.79M after | |
| Dec 29, 2025 (view filing) | Dec 24-26 | 5 days | Frost Phillip MD Et AlDirector, 10% Owner | PPurchase | +65.0K | $0.97 | +$63.0K | +3.8%1.77M after | 2 lots |
| Nov 28, 2025 (view filing) | Nov 26 | 2 days | Frost Phillip MD Et AlDirector, 10% Owner | PPurchase | +4.00K | $0.9938 | +$3.98K | +0.2%1.70M after | 2 lots |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Frost Phillip MD Et AlDirector, 10% Owner | PPurchase | +20.0K | $0.94 | +$18.8K | +1.2%1.70M after | |
| Apr 6, 2023 (view filing)4:01 PM ET | Apr 4 | 2 days | Frost Phillip MD Et Al and 1 otherDirector, 10% Owner | PPurchase | +1.02M | $1.97 | +$2.00M | +333.3%1.32M after | |
| Aug 23, 2021 (view filing) | Aug 20 | 3 days | Pfenniger Richard C JrDirector | PPurchase | +40.0K | $1.03 | +$41.2K | New position40.0K after |